1
Darwin J Prockop, Ruth F Pereira, Dennis B Leeper, Michael D O Hara: Isolated stromal cells for treating diseases, disorders or conditions characterized by bone defects. Thomas Jefferson University, Woodcock Washburn Kurtz Mackiewicz & Norris, February 10, 1998: US05716616 (113 worldwide citation)

Methods of treating patients who are suffering from a disease, disorder or condition characterized by a bone cartilage or lung defect are disclosed. The methods comprising the step of intravenous administration of stromal cells isolated from normal syngeneic individuals or intravenous administration ...


2
Darwin J Prockop, Ruth F Pereira, Dennis B Leeper, Michael D O Hara, Joseph Kulkosky, Donald Phinney, Alexey Laptev: Isolated stromal cells and methods of using the same. Thomas Jefferson University, Drinker Biddle & Reath, December 13, 2005: US06974571 (2 worldwide citation)

Methods of treating patients who are suffering from a disease, disorder or condition characterized by a bone cartilage or lung defect are disclosed. The methods comprising the step of intravenous administration of stromal cells isolated from normal syngeneic individuals or intravenous administration ...


3
Darwin J Prockop, Ruth F Pereira, Dennis B Leeper, Michael D O Hara, Joseph Kulkosky, Donald Phinney, Alexey Laptev, Jose Caro: Isolated stromal cells and methods of using the same. Thomas Jefferson University, Morgan Lewis & Bockius, August 26, 2004: US20040166097-A1

Methods of treating patients who are suffering from a disease, disorder or condition characterized by a bone cartilage or lung defect are disclosed. The methods comprising the step of intravenous administration of stromal cells isolated from normal syngeneic individuals or intravenous administration ...


4
Darwin J Prockop, Ruth F Pereira, Dennis B Leeper, Michael D O Hara, Joseph Kulkosky, Donald Phinney, Alexey Laptev, Jose Caro: Isolated stromal cells and methods of using the same. Thomas Jefferson University, Morgan Lewis & Bockius, October 30, 2003: US20030202966-A1

Methods of treating patients who are suffering from a disease, disorder or condition characterized by a bone cartilage or lung defect are disclosed. The methods comprising the step of intravenous administration of stromal cells isolated from normal syngeneic individuals or intravenous administration ...


5
Darwin J Prockop, Ruth F Pereira, Dennis B Leeper, Michael D O Hara, Joseph Kulkosky, Donald Phinney, Alexey Laptev: Isolated stromal cells and methods of using the same. Morgan Lewis & Bockius, March 27, 2003: US20030059412-A1

Methods of treating patients who are suffering from a disease, disorder or condition characterized by a bone cartilage or lung defect are disclosed. The methods comprising the step of intravenous administration of stromal cells isolated from normal syngeneic individuals or intravenous administration ...


6
Michael D O Hara: Radioprotective compound coating for medical devices. Philip S Johnson, Johnson & Johnson, August 25, 2005: US20050187608-A1

Medical devices, and in particular implantable medical devices, may be coated to minimize or substantially eliminate a biological organism's reaction to the introduction of the medical device to the organism. The medical devices may be coated with any number of biocompatible materials. Therapeutic d ...


7
Darwin J Prockop, Ruth F Pereira, Dennis B Leeper, Michael D O Hara, Joseph Kulkosky, Donald Phinney, Alexey Laptev, Jose Caro: Isolated stromal cells and methods of using the same. Thomas Jefferson University, Seed Intellectual Property Law Group Pllc, February 5, 2009: US20090035347-A1

Methods of treating patients who are suffering from a disease, disorder or condition characterized by a bone cartilage or lung defect are disclosed. The methods comprising the step of intravenous administration of stromal cells isolated from normal syngeneic individuals or intravenous administration ...


8
Darwin J Prockop, Ruth F Pereira, Dennis B Leeper, Michael D O Hara, Joseph Kulkosky, Donald Phinney, Alexey Laptev, Jose Caro: Isolated stromal cells and methods of using the same. Thomas Jefferson University, Seed Intellectual Property Law Group Pllc, January 14, 2010: US20100008964-A1

Methods of treating patients who are suffering from a disease, disorder or condition characterized by a bone cartilage or lung defect are disclosed. The methods comprising the step of intravenous administration of stromal cells isolated from normal syngeneic individuals or intravenous administration ...


9
Darwin J Prockop, Ruth F Pereira, Dennis B Leeper, Michael D O Hara, Joseph Kulkosky, Donald Phinney, Alexey Laptev, Jose Caro: Isolated stromal cells and methods of using the same. August 23, 2012: US20120213752-A1

Isolated stromal cells, containers comprising isolated stromal cells transfected with exogenous DNA, and methods of treating patients suffering from diseases characterized by a bone cartilage or lung defect are disclosed. The methods comprise obtaining a bone marrow sample from a donor, isolating st ...


10
Michael D O Hara: Radioprotective compound coating for medical device. Cordis, September 15, 2005: JP2005-246056

PROBLEM TO BE SOLVED: To provide an implantable medical device that may be coated to minimize or substantially eliminate a biological vital reaction.SOLUTION: The medical device comprises at least one kind of radioprotective composition or compound incorporated into a polymeric matrix fixed to the s ...



Click the thumbnails below to visualize the patent trend.